12 Types of Doctors Who Help with Multiple Sclerosis
Medically reviewed by Seunggu Han, M.D. — Written by June Halper, MSN, APN-C, FAAN, MSCN — Updated on August 5,…
RSVP for MS Webinars on February 8th & 9th for: Pelvic Floor Rehabilitation; Strengthening & Stretching; MS Symptoms Management, Treatment updates and more…
For February 8th – This presentation on Pelvic Floor & Bladder Issues in MS – Understanding avenues of therapy…
Stuart Schlossman
EBV and MS: Is Multiple Sclerosis Really ‘Long Mono’?
New research strengthens the connection between the Epstein-Barr virus, the cause of most cases of mononucleosis, and MS. By Trevis…
Stuart Schlossman
COVID May Affect Spinal Fluid, Causing ‘Brain Fog,’ Study Says
Ralph Ellis – January 21, 2022 Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource…
Stuart Schlossman
January 2022 – This message is geared towards people with MS – about how to get reimbursement for home tests/get free home tests
Reimbursing Your At-Home COVID-19 Tests January 24, 2022 On January 10, 2022, the Biden Administration issued guidance that required private…
Stuart Schlossman
Bite, Chew, Swallow: How to Deal With Dysphagia When You Have MS
Trouble with swallowing is both frightening and unpleasant, but help is available to make eating and drinking easier. By Becky UphamMedically…
Stuart Schlossman
Evusheld for Pre-exposure Prevention of COVID-19 – This prevention medication is strictly for those who are not expected to have adequate immune responses to the vaccine
Last updated: December 17, 2021 The U.S. Food and Drug Administration (FDA) has authorized Evusheld (tixagevimab co-packaged with cilgavimab) as a…
Stuart Schlossman
COVID-19 Studies Recruiting People with MS
Overview The National MS Society is partnering with organizations and supporting research that seeks to understand the impacts of…
Stuart Schlossman
Delaying b-cell depleters (Ocrevus, kesimpta, rituximab) increases the chance of getting protective antibodies after covid-19 vaccination
January 13, 2022 Seroconversion following COVID-19 vaccination: Can we optimize protective response in CD20-treated individuals? Abstract Although there is an…
Stuart Schlossman
COVID-19 Vaccine Response in People with Multiple Sclerosis
Abstract Objective: The purpose of this study was to investigate the effect of disease modifying therapies on immune response to…
Stuart Schlossman
